天奇股份(002009.SZ):參股公司天安智聯3月19日起於新三板退市
格隆匯3月18日丨天奇股份(002009.SZ)公佈,公司於近日收到參股公司天安智聯的通知,天安智聯於2021年3月17日收到全國中小企業股份轉讓系統有限責任公司出具的《關於同意江蘇天安智聯科技股份有限公司股票終止在全國中小企業股份轉讓系統掛牌的函》(股轉系統函【2021】646號),同意天安智聯股票終止在全國中小企業股份轉讓系統掛牌。
天安智聯目前正在按照有關規定辦理終止掛牌手續,其股票自2021年3月19日起終止在全國中小企業股份轉讓系統掛牌。截至目前,公司持有天安智聯6.0797%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.